Skip to Main Content
Diseases of the Cardiovascular System

Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

What is the purpose of this trial?

The purpose of this clinical study is to evaluate the safety and effectiveness of an investigational device, the LimFlow Stent Graft System, designed to create a connection between the artery and vein in the Below-The-Knee (BTK) vascular system. This procedure is intended to restore blood flow to the foot and is only for patients with “chronic limb-threatening ischemia” that are not likely to be helped with standard operations or procedures. The LimFlow System is available only as an experimental device as a part of this clinical trial, and cannot be provided unless you agree to participate in the research.

  • Trial with
    LimFlow SA
  • Ages
    18 years - 95 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Cassius Iyad Ochoa Chaar

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    06/09/2024
  • Study HIC
    #2000032835